Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice

Brain Research Bulletin

Volumn 67, Issue 1-2, 2005, Pages 156-160

  Kalueff, Allan V ^a,b   Minasyan, Anna ^a   Tuohimaa, Pentti ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

1,25 Dihydroxyvitamin D; Chemically induced seizures; Epilepsy; Mice; Vitamin D

Indexed keywords

CALCITRIOL; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LATENT PERIOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEIZURE SUSCEPTIBILITY;

ANIMALS; ANTICONVULSANTS; BRAIN; CALCITRIOL; CONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY; INJECTIONS, SUBCUTANEOUS; MICE; MORTALITY; PENTYLENETETRAZOLE; REACTION TIME; TIME FACTORS;

EID: 24044468728     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2005.06.022     Document Type: Article

References (33)

1. F.E. Ali, M.A. Al-Bustan, W.A. Al-Busairi, and F. Al-Mulla Loss of seizure control due to anticonvulsant-induced hypocalcemia Ann. Pharmacother. 38 2004 1002 1004
2. C. Armelisasso, M.L. Vaccario, A. Pontecorvi, and S. Mazza Tonic-clonic seizures in a patient with primary hypoparathyroidism: a case report Clin. EEG Neurosci. 35 2004 97 99
3. L.D. Brewer, V. Thibault, K.C. Chen, M.C. Langub, P.W. Landfield, and N.M. Porter Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons J. Neurosci. 21 2001 98 108
4. S. Carswell Vitamin D in the nervous system: actions and therapeutic potential. D. Feldman F.H. Glorieux J.W. Pike Vitamin D 1997 Academic Press San-Diego 1197 1211
5. C. Christiansen, P. Rorbro, and O. Sjo "Anticonvulsant" action of Vitamin D in epileptic patiens? A controlled pilot study Br. Med. J. 2 1974 258 259
6. M.K. Drezner Treatment of anticonvulsant drug-induced bone disease Epilepsy Behav. 5 2004 41 47
7. L. Fitzpatrick Pathophysiology of bone loss in patients receiving anticonvulsant therapy Epilepsy Behav. 5 2005 S1 S15
8. E. Garcion, N. Wion-Barbot, C.N. Montero-Menei, F. Berger, and D. Wion New clues about Vitamin D functions in the nervous system Tr. Endocrinol. Metab. 13 2002 100 106
9. M.M. Gupta, and D.N. Grover Hypocalcemia and convulsions Postgrad. Med. J. 53 1977 330 333
10. A.F. Hess Pathogenesis of rickets Rickets Including Osteomalacia and Tetany 1929 Lea and Febiger Philadelphia pp. 130-142
11. C.C. Hoecker, and J.T. Kanegaye Recurrent febrile seizures: an unusual presentation of nutritional rickets J. Emerg. Med. 23 2002 367 370
12. M. Holick Stay tuned to PXR: an orphan actor that may not be D-structive only to bone J. Clin. Invest. 115 2005 32 34
13. T. Ishikawa, K. Kawai, M. Kanayama, and Y. Wada Increased serum creatine kinase due to hypocalcemia in Vitamin D deficiency Pediatr. Neurol. 3 1987 37 39
14. G.H. Johnson, and F. Willis Seizures as the presenting feature of rickets in an infant Med. J. Aust. 178 2003 467
15. A.V. Kalueff, K.O. Eremin, and P. Tuohimaa Mechanisms of neuroprotective action of Vitamin D3 Biokhimia 69 2004 907 911
16. A.V. Kalueff, K. Lehtimaki, A. Ylinen, J. Honkaniemi, and J. Peltola Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats Neurosci. Lett. 2004 106 110
17. A.V. Kalueff, Y-R. Lou, I. Laaksi, and P. Tuohimaa Increased anxiety in mice lacking Vitamin D receptor gene Neuroreport 15 2004 1271 1274
18. R. Losel, and M. Wehling Nongenomic actions of steroid hormones Nat. Rev. 4 2003 46 56
19. A.E. Medina, A.C. Manhaes, and S.L. Schmidt Sex differences in sensitivity to seizures elicited by pentylenetetrazol in mice Pharmacol. Biochem. Behav. 68 2001 591 596
20. M. Mikawi, R.H. Wakim, and M. Fayad Symptomatic antiepileptic drug associated Vitamin D deficiency in noninstitutionalized patients: an under-diagnosed disorder J. Med. Liban. 51 2003 71 73
21. I. Neveu, P. Naveilhan, C. Menaa, D. Wion, P. Brachet, and M. Garabedian Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro J. Neurosci. Res. 38 1994 214 220
22. A.W. Norman, W.H. Okamura, J.E. Bishop, and H.L. Henry Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3 Mol. Cell Endocrinol. 197 2002 1 13
23. G. Offermann, V. Pinto, and R. Kruse Antiepileptic drugs and Vitamin D supplementation Epilepsia 20 1979 3 15
24. J. Oki, M. Takedatsu, J. Itoh, K. Yano, K. Cho, and A. Okuno Hypocalcemic focal seizures in a one-month-old infant of a mother with a low circulating level of Vitamin D Brain Dev. 13 1991 132 134
25. A.M. Pack Bone disease in epilepsy Curr. Neurol. Neurosci. Rep. 4 2004 329 334
26. A.M. Pack, and M.J. Morrell Epilepsy and bone health in adults Epilepsy Behav. 5 2004 24 29
27. J.M. Pascussi, A. Robert, M. Nguyen, O. Walrant-Debray, M. Garabedian, P. Martin, T. Pineau, J. Saric, F. Navarro, P. Maurel, and M.J. Vilarem Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia J. Clin. Invest. 115 2005 177 186
28. I. Pela, R. Bini, and D. Seracini Vitamin D-dependent type-1 rickets: diagnosis and treatment of a further case Pediatr. Med. Chir. 18 1996 207 209
29. A. Siegel, L. Malkowitz, M.J. Moscowitz, and S. Christakos Administration of 125-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats Brain Res. 298 1984 125 129
30. M.D. Swedberg, P. Jacobsen, and T. Honore Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl- benzo(f)quinoxaline (NBQX) J. Pharmacol. Exp. Ther. 274 1995 1113 1121
31. M. Tetich, M. Dziedzicka-Wasylewska, M. Kusmider, A. Kutner, M. Leskiewicz, L. Jaworska-Feil, B. Budziszewska, M. Kubera, A.M. Myint, A. Basta-Kaim, M. Skowronski, and W. Lason Effects of PRI-2191-A low-calcemic analog of 1,25-dihydroxyvitamin D(3) on the seizure-induced changes in brain gene expression and immune system activity in the rat Brain Res. 1039 2005 1 13
32. J.M. Tusell, M. Vendrell, J. Serratosa, and R. Trullas Lindane-induced convulsions in NMRI and OF1 mice: antagonism with (+)MK-801 and voltage-dependent calcium channel blockers Brain Res. 593 1992 209 214
33. http://aretha.jax.org/pub-cgi/phenome/mpdcgi, The Mouse Phenome Database (project: Frankel and White), The Jackson Laboratory, Bar Harbor, Maine, USA, 2001-2005.